Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05987917 · ClinicalTrials.gov registry record · NA
Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05987917 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 7 participants.
The verdict
NCT05987917, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will evaluate the clinical efficacy, safety and the performance of the BTL-785-2 applicator of the BTL-785F system for non-invasive treatment of facial wrinkles and correcting facial skin laxity.
Interventions
- OTHER No Treatment
- DEVICE BTL-785-2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2022-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05987917
The ClinicalTrials.gov registry entry for NCT05987917 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No Treatment is the first listed.
NCT05987917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05987917 about?
NCT05987917 is a clinical study titled "Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation". This study will evaluate the clinical efficacy, safety and the performance of the BTL-785-2 applicator of the BTL-785F system for non-invasive treatment of facial wrinkles and correcting facial skin laxity.
What is the current status of trial NCT05987917?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-01-25. Estimated completion is 2022-01-03.
What interventions are being tested in trial NCT05987917?
The interventions under investigation include: No Treatment (OTHER), BTL-785-2 (DEVICE).
Who is sponsoring clinical trial NCT05987917?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.